[go: up one dir, main page]

NO20061100L - Amidderivater - Google Patents

Amidderivater

Info

Publication number
NO20061100L
NO20061100L NO20061100A NO20061100A NO20061100L NO 20061100 L NO20061100 L NO 20061100L NO 20061100 A NO20061100 A NO 20061100A NO 20061100 A NO20061100 A NO 20061100A NO 20061100 L NO20061100 L NO 20061100L
Authority
NO
Norway
Prior art keywords
hsv
infection
amide derivatives
caused
famihen
Prior art date
Application number
NO20061100A
Other languages
English (en)
Other versions
NO335467B1 (no
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Tomoaki Kawano
Akio Kamikawa
Hirosh Suzuki
Kenji Dudo
Original Assignee
Rational Drug Design Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rational Drug Design Lab filed Critical Rational Drug Design Lab
Publication of NO20061100L publication Critical patent/NO20061100L/no
Publication of NO335467B1 publication Critical patent/NO335467B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)

Abstract

Forbindelse som er anvendelig i legemidler mot sykdommer forårsaket av infeksjon med virus tilhørende famihen herpesviridae, så som varicella forårsaket av infeksjon med varicellazoster-virus, herpes-zoster forårsaket av tilbakevendende infeksjon med persisterende varicellazoster-virus, labial herpes og herpes encifalitt forårsaket av infeksjon med HSV-1, genitalherpes forårsaket av infeksjon med HSV-2, etc. Et derivat av N-{2-[(4-substituert fenyl)amino]-2-oksoetyl}tettahydro-2H-tiopyran-4- karboksamid med en spesifikk 5- eller 6-leddet heteroaiylsubstituent i 4-posisjonen har en gunstig antiviral aktivitet og gjør det mulig å behandle sykdommer med oral administtasjon i liten dose.
NO20061100A 2003-08-08 2006-03-07 Amidderivater, og et farmasøytisk preparat derav som et medikament mot herpesvirus NO335467B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003290850 2003-08-08
PCT/JP2004/011573 WO2005014559A1 (ja) 2003-08-08 2004-08-05 アミド誘導体

Publications (2)

Publication Number Publication Date
NO20061100L true NO20061100L (no) 2006-03-07
NO335467B1 NO335467B1 (no) 2014-12-15

Family

ID=34114142

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061100A NO335467B1 (no) 2003-08-08 2006-03-07 Amidderivater, og et farmasøytisk preparat derav som et medikament mot herpesvirus

Country Status (19)

Country Link
US (2) US7465748B2 (no)
EP (1) EP1652843B1 (no)
JP (1) JP4549974B2 (no)
KR (1) KR101157074B1 (no)
CN (1) CN100445271C (no)
AU (1) AU2004263448B2 (no)
BR (1) BRPI0413430B8 (no)
CA (1) CA2535199C (no)
CY (1) CY1115461T1 (no)
DK (1) DK1652843T3 (no)
ES (1) ES2462292T3 (no)
MX (1) MXPA06001526A (no)
NO (1) NO335467B1 (no)
PL (1) PL1652843T3 (no)
PT (1) PT1652843E (no)
RU (1) RU2336273C2 (no)
SI (1) SI1652843T1 (no)
TW (1) TW200505894A (no)
WO (1) WO2005014559A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305648A1 (en) * 2001-12-21 2011-04-06 Novo Nordisk A/S Amide derivatives useful as glucokinase activators
CA2488642C (en) * 2002-06-27 2011-09-06 Dharma Rao Polisetti Aryl carbonyl derivatives as glucokinase activators
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
SI1723128T1 (sl) 2004-01-06 2013-04-30 Transtech Pharma, Inc. Heteroaril uree in njihova uporaba kot aktivatorji glukokinaze
JPWO2006082821A1 (ja) * 2005-02-02 2008-06-26 アステラス製薬株式会社 ヘルペスウイルスが関与する疾患の予防若しくは治療剤
EP1844776B1 (en) * 2005-02-02 2010-04-28 Astellas Pharma Inc. Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
ES2347681T3 (es) * 2005-02-02 2010-11-03 Astellas Pharma Inc. Agentes para tratar el herpes genital despues de su aparicion.
JP5011739B2 (ja) * 2005-02-03 2012-08-29 アステラス製薬株式会社 テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体を含有する医薬組成物
EP1904466A1 (en) * 2005-07-08 2008-04-02 Novo Nordisk A/S Dicycloalkyl urea glucokinase activators
JP2009500378A (ja) * 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー／エス グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
EP2377856A1 (en) 2005-07-14 2011-10-19 Novo Nordisk A/S Urea glucokinase activators
EP2118083A1 (en) * 2007-01-09 2009-11-18 Novo Nordisk A/S Urea glucokinase activators
CA2675111C (en) 2007-01-11 2016-04-05 Novo Nordisk A\S Urea glucokinase activators
DE102008014523A1 (de) * 2008-03-15 2009-09-17 Robert Bosch Gmbh Heizgerät
EP2263671B1 (en) * 2008-04-02 2016-07-20 Astellas Pharma Inc. Amide derivative-containing pharmaceutical composition
BRPI0912778B1 (pt) * 2008-05-14 2019-04-30 Astellas Pharma Inc. Composto de amida, composição farmacêutica compreendedo dito composto e uso do mesmo para o tratamento de insuficiência renal crônica ou nefropatia diabética
EP2351565A1 (en) 2008-10-20 2011-08-03 Astellas Pharma Inc. Medicine for preventing or treating pain related to herpes zoster
CN108623577B (zh) * 2018-05-08 2020-09-25 山东百诺医药股份有限公司 阿莫奈韦及其中间体的制备方法
EP4487909A3 (en) 2018-06-12 2025-03-19 vTv Therapeutics LLC Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
WO2020038812A1 (en) * 2018-08-20 2020-02-27 Rijksuniversiteit Groningen New process for the preparation of amenamevir
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑
WO2021167840A1 (en) 2020-02-18 2021-08-26 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288091B1 (en) * 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
ATE227279T1 (de) 1995-12-29 2002-11-15 Boehringer Ingelheim Pharma Phenyl thiazol derivate mit antiherpesvirus eigenschaften
AU3289299A (en) * 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
WO2000053591A1 (de) * 1999-03-08 2000-09-14 Bayer Aktiengesellschaft Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
EP1185508A2 (en) 1999-05-24 2002-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
US6545055B1 (en) 1999-05-24 2003-04-08 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
CA2428184C (en) * 2000-11-10 2010-03-30 Yamanouchi Pharmaceutical Co., Ltd. Thiazolylphenylcarbamoylmethyl amide derivative
DE10139060A1 (de) 2001-08-08 2003-02-20 Merck Patent Gmbh Phenylderivate
WO2003095435A1 (en) 2002-05-09 2003-11-20 Yamanouchi Pharmaceutical Co., Ltd. Amide derivatives
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative

Also Published As

Publication number Publication date
TWI341311B (no) 2011-05-01
EP1652843B1 (en) 2014-04-02
CN1832930A (zh) 2006-09-13
CA2535199A1 (en) 2005-02-17
US20050032855A1 (en) 2005-02-10
DK1652843T3 (da) 2014-05-05
WO2005014559A1 (ja) 2005-02-17
PT1652843E (pt) 2014-06-02
US20060229295A1 (en) 2006-10-12
KR20060073928A (ko) 2006-06-29
AU2004263448A1 (en) 2005-02-17
CA2535199C (en) 2010-12-14
RU2006106922A (ru) 2006-08-27
US6903125B2 (en) 2005-06-07
BRPI0413430B1 (pt) 2019-04-30
MXPA06001526A (es) 2006-05-25
CY1115461T1 (el) 2017-01-04
SI1652843T1 (sl) 2014-06-30
BRPI0413430A (pt) 2006-10-17
JPWO2005014559A1 (ja) 2006-10-05
US7465748B2 (en) 2008-12-16
KR101157074B1 (ko) 2012-06-22
RU2336273C2 (ru) 2008-10-20
EP1652843A1 (en) 2006-05-03
BRPI0413430B8 (pt) 2021-05-25
AU2004263448B2 (en) 2009-02-05
EP1652843A4 (en) 2010-07-28
ES2462292T3 (es) 2014-05-22
CN100445271C (zh) 2008-12-24
JP4549974B2 (ja) 2010-09-22
TW200505894A (en) 2005-02-16
NO335467B1 (no) 2014-12-15
PL1652843T3 (pl) 2014-09-30

Similar Documents

Publication Publication Date Title
NO20061100L (no) Amidderivater
NO20072689L (no) Tetrasykliske indolderivater som antivirale midler
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
BR0010476A (pt) Compostos derivados do 4,5,6,7-tetrahidroindazol e seu uso como agentes antitumorais
WO2006027628A3 (en) Naphthalimide derivatives as antiviral agents
DE60322423D1 (de) Pyrrolidin- und azetidinverbindungen alsccr5-antagonisten
NO20092399L (no) Kjemiske forbindelser
BRPI0511283A (pt) aril aciltiouréias substituìdas e compostos relacionados; inibidores da replicação viral
DE60324014D1 (de) Heterocyclische verbindungen alsccr5-antagonisten
DE602006014367D1 (de) Multimere von pyrimidinonderivaten und deren verwendung als inhibitoren der humanen neutrophilelastase
BRPI0513863A (pt) derivados de uréia cìclica substituìda por heterociclo, preparação dos mesmos e uso farmacêutico dos mesmos como inibidores de cinase
BRPI0512330A (pt) derivados de pirazol-pirimidina
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
ATE405269T1 (de) Cyclohexylverbindungen als ccr5-antagonisten
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
BRPI0507675A (pt) derivados de 2'-c-metil nucleosìdeo
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
BRPI0416450A (pt) derivados de ácido fosfìnico, inibidores de beta - secretase para o tratamento de mal de alzheimer
ATE450498T1 (de) Cycloalken-dicarbonsäure-verbindungen als entzündungshemmende, immunmodulatorische und antiproliferative mittel
ATE508125T1 (de) Triazoloanilinopyrimidinderivate zur verwendung als antivirale mittel
DE60227100D1 (de) Dimere verbindungen und deren verwendung als antivirale mittel
MXPA05012369A (es) Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina.
ATE181918T1 (de) Purinderivate und ihre pharmazeutisch akzeptablen salze
MXPA05012772A (es) Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina.